Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
11 active NDC listing: 1 human prescription drug. By marketing category: NDA 1.
| Dosage form | NDCs |
|---|---|
| tablet | 1 |
| Route | NDCs |
|---|---|
| oral | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| luria therapeutics llc | 1 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Varubi | rolapitant | tablet, oral | 87628-101NDA |
Compare
Other companies listing rolapitant
- TerSera Therapeutics LLC0 sites · 9 NDC
Enquiry
Common questions
- Is Luria Therapeutics LLC FDA approved?
- Luria Therapeutics LLC holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Luria Therapeutics LLC make?
- 1 product is listed under Luria Therapeutics LLC in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.